Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Schmidt

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Alzheimer'S Research & Therapy|January 27, 2018
Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathologyJelle Praet, Nikolay V Manyakov, Leacky Muchene, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 17, 2025
The efficacy of elevating anandamide via inhibition of fatty acid amide hydrolase (FAAH) combined with internet-delivered cognitive behavioral therapy in the treatment of post-traumatic stress disorder: a randomized, placebo-controlled clinical trialLeah M Mayo, Emelie Gauffin, Gavin N Petrie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2011
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Alzheimer'S Research & Therapy|November 1, 2018
Secondary prevention of Alzheimer's dementia: neuroimaging contributionsMara Ten Kate, Silvia Ingala, Adam J Schwarz, et al.
Journal of Medicinal Chemistry|January 21, 2017
Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer's DiseaseFrederik J R Rombouts, José-Ignacio Andrés, Manuela Ariza, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 13, 2013
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Neurology|July 26, 2015
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trialsEnchi Liu, Mark E Schmidt, Richard Margolin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 20, 2018
AMYPAD Diagnostic and Patient Management Study: Rationale and designGiovanni B Frisoni, Frederik Barkhof, Daniele Altomare, et al.
Neurology|July 18, 2020
Multitracer model for staging cortical amyloid deposition using PET imagingLyduine E Collij, Fiona Heeman, Gemma Salvadó, et al.
Alzheimer'S Research & Therapy|April 17, 2026
Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS studyNúria Tort-Colet, Laura Stankeviciute, Ana Fernández-Arcos, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Alzheimer'S Research & Therapy|January 27, 2018
Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathologyJelle Praet, Nikolay V Manyakov, Leacky Muchene, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 17, 2025
The efficacy of elevating anandamide via inhibition of fatty acid amide hydrolase (FAAH) combined with internet-delivered cognitive behavioral therapy in the treatment of post-traumatic stress disorder: a randomized, placebo-controlled clinical trialLeah M Mayo, Emelie Gauffin, Gavin N Petrie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2011
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Alzheimer'S Research & Therapy|November 1, 2018
Secondary prevention of Alzheimer's dementia: neuroimaging contributionsMara Ten Kate, Silvia Ingala, Adam J Schwarz, et al.
Journal of Medicinal Chemistry|January 21, 2017
Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer's DiseaseFrederik J R Rombouts, José-Ignacio Andrés, Manuela Ariza, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 13, 2013
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Neurology|July 26, 2015
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trialsEnchi Liu, Mark E Schmidt, Richard Margolin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 20, 2018
AMYPAD Diagnostic and Patient Management Study: Rationale and designGiovanni B Frisoni, Frederik Barkhof, Daniele Altomare, et al.
Neurology|July 18, 2020
Multitracer model for staging cortical amyloid deposition using PET imagingLyduine E Collij, Fiona Heeman, Gemma Salvadó, et al.
Alzheimer'S Research & Therapy|April 17, 2026
Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS studyNúria Tort-Colet, Laura Stankeviciute, Ana Fernández-Arcos, et al.
Pageof 7